3-D Matrix, Ltd. (7777.T) has a MoatMap StockRank of 27/100 based on Quality (56/100), Value (24/100), and Momentum (34/100) factor scores. The current signal is SELL.
3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields.
| Price | $2.70 |
| Market Cap | $331M |
| P/E (Forward) | -34.38 |
| Price/Book | 10.54 |
| Return on Equity | 31.9% |
| Return on Invested Capital | -48.7% |
| Debt/Equity | 11.10 |
| Gross Margin | 70.6% |
| Operating Margin | 13.7% |
| Revenue Growth | 42.2% |
| Free Cash Flow | $-67K |
3-D Matrix, Ltd. operates in the Medical Devices industry, part of the Healthcare sector (Japan).